SCHD vs DGRO: returns, risk and drawdowns compared
Schwab U.S. Dividend Equity ETF against iShares Core Dividend Growth ETF, over the same 12 years (July 2014 to October 2026) with dividends reinvested.
Data updated October 2026
SCHD
Schwab U.S. Dividend Equity ETF
10,000 became
33,230
- A year on average
- +10.2%
- Annual volatility
- 14.8%
- Deepest fall
- −22.1%
- Worst month
- −12.5%
DGRO
iShares Core Dividend Growth ETF
10,000 became
41,678
- A year on average
- +12.3%
- Annual volatility
- 13.5%
- Deepest fall
- −21.9%
- Worst month
- −12.8%
DGRO came out ahead by 2.0 percentage points a year from July 2014 to October 2026. SCHD swung more (14.8% against 13.5% a year). The correlation of monthly returns was 0.94: they moved almost in lockstep.
Growth of 10,000: SCHD vs DGRO
Who was ahead, and when
The gap between the two over the previous three years, at each month-end. Above zero SCHD had returned more, below zero DGRO. SCHD was ahead in 14% of the 113 three-year periods.
Annualised 3-year return of SCHD minus that of DGRO, in percentage points a year.
Falls from the previous high
Month-end values. Deepest fall: SCHD −22.1%, DGRO −21.9%.
All the figures
| SCHD | DGRO | |
|---|---|---|
| Annual return (CAGR) | +10.2% | +12.3% |
| Total return | +232% | +317% |
| Annual volatility | 14.8% | 13.5% |
| Deepest fall (month-end) | −22.1% | −21.9% |
| Worst month | −12.5% | −12.8% |
| Best month | +13.2% | +12.1% |
| Positive months | 59% | 67% |
| Best year | 2021: +27.3% | 2019: +29.9% |
| Worst year | 2018: −7.3% | 2022: −7.9% |
| 1-year return | +37.2% | +18.0% |
| 5 years, a year | +8.5% | +10.9% |
| 10 years, a year | +11.5% | +13.8% |
| Trading currency | USD | USD |
First nine rows: the same 148 months for both funds. Trailing returns: to each fund’s last close.
Year by year
Full calendar years both funds were trading. The higher of the two each year is in bold.
Holding both: half SCHD, half DGRO
| SCHD alone | DGRO alone | 50/50 | |
|---|---|---|---|
| A year on average | +10.2% | +12.3% | +11.3% |
| Annual volatility | 14.8% | 13.5% | 14.0% |
| Deepest fall (month-end) | −22.1% | −21.9% | −22.0% |
| Worst month | −12.5% | −12.8% | −12.7% |
With a correlation of 0.94 the mix behaved almost like either fund alone: its volatility of 14.0% sits between the two. Rebalanced to 50/50 every month, before costs.
Questions
Which has returned more, SCHD or DGRO?
From July 2014 to October 2026, SCHD returned +10.2% a year and DGRO +12.3% a year, with dividends reinvested. Over rolling 3-year periods SCHD did better in 14% of cases. Past returns do not predict future returns.
Which is riskier, SCHD or DGRO?
Over the same months annual volatility was 14.8% for SCHD and 13.5% for DGRO; the deepest fall from a month-end high was 22.1% and 21.9%, and the worst single month −12.5% and −12.8%.
How correlated are SCHD and DGRO?
The correlation of their monthly returns was 0.94: they moved almost in lockstep. Holding both adds little diversification compared with holding one.
What about holding both SCHD and DGRO?
Half in each, rebalanced every month, returned +11.3% a year over the same period, with 14.0% annual volatility and a deepest month-end fall of 22.0%.
More comparisons
- SCHD — Schwab U.S. Dividend Equity ETFReturns, drawdowns and risk
- DGRO — iShares Core Dividend Growth ETFReturns, drawdowns and risk
- SCHD vs VYM
- SCHD vs VIG
- VOO vs SCHD
- SCHD vs JEPI
- VYM vs DGRO
- VIG vs DGRO
- Portfolio backtesting, explainedRebalancing, costs and attribution
- Portfolio analytics software comparedFeatures and prices side by side
How the figures are calculated
Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.
The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.